A detailed history of Whittier Trust CO Of Nevada Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 202 shares of FOLD stock, worth $1,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
202
Previous 329 38.6%
Holding current value
$1,979
Previous $3,000 33.33%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$9.55 - $12.09 $1,212 - $1,535
-127 Reduced 38.6%
202 $2,000
Q1 2024

May 02, 2024

SELL
$11.43 - $14.24 $251 - $313
-22 Reduced 6.27%
329 $3,000
Q2 2023

Jul 24, 2023

BUY
$10.72 - $13.3 $75 - $93
7 Added 2.03%
351 $4,000
Q1 2023

Apr 21, 2023

BUY
$10.91 - $13.54 $3,753 - $4,657
344 New
344 $3,000

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.75B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.